Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Advanced Health Intelligence's enterprise value is A$19.73 Mil.
Advanced Health Intelligence's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was A$-7.31 Mil. Therefore, Advanced Health Intelligence's EV-to-EBITDA for today is -2.70.
The historical rank and industry rank for Advanced Health Intelligence's EV-to-EBITDA or its related term are showing as below:
ASX:AHI's EV-to-EBITDA is not ranked *
in the Software industry.
Industry Median: 10.5 * Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Advanced Health Intelligence (ASX:AHI) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Advanced Health Intelligence's PE Ratio (TTM) for today is calculated as:
Advanced Health Intelligence's share price for today is A$0.092.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Advanced Health Intelligence's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was A$-0.035.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AHI vs PRST, LAAB, VRTC: EV-to-EBITDA Comparison
For the Software - Application subindustry, Advanced Health Intelligence's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Health Intelligence EV-to-EBITDA vs Software Industry
For the Software industry and Technology sector, Advanced Health Intelligence's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Advanced Health Intelligence's EV-to-EBITDA falls into.
Advanced Health Intelligence's current Enterprise Value is A$19.73 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Advanced Health Intelligence's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was A$-7.31 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Health Intelligence (ASX:AHI) has a EV-to-EBITDA of -2.70 as of Aug. 04, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Advanced Health Intelligence.
Is Advanced Health Intelligence's EV-to-EBITDA too high?
Advanced Health Intelligence's current EV-to-EBITDA is -2.70.
How does Advanced Health Intelligence's EV-to-EBITDA compare to PRST and LAAB?
Advanced Health Intelligence's EV-to-EBITDA of -2.70 can be compared against companies in the Software industry. The industry median EV-to-EBITDA is 10.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Software company?
The median EV-to-EBITDA among Software companies is 10.50, based on 1,960 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Advanced Health Intelligence. For the Software industry, the median EV-to-EBITDA is 10.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Health Intelligence's current EV-to-EBITDA is -2.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Health Intelligence stock overvalued right now?
Advanced Health Intelligence (ASX:AHI) has a current EV-to-EBITDA of -2.70. The current EV-to-EBITDA is -2.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Advanced Health Intelligence (ASX:AHI), the current EV-to-EBITDA is -2.70 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Advanced Health Intelligence Ltd (AHI) is engaged in developing and delivering user-friendly biometric scans to render vital signs and health risk estimates to a smartphone. By leveraging the smartphone with purpose-built computer vision, machine learning models, and patented algorithms, AHI provides a private and secure way for individuals to perform biometric health-risk assessment and stratification. AHI's technology delivers simple-to-use, scalable, and cost-effective means to enable individuals to check, track and act towards better health outcomes. The combination of the patented and proprietary BodyScan dimensioning and composition capabilities and, FaceScan to return vital signs enables a unique health assessment capability made accessible anytime, anywhere through the smartphone.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHI has been successfully added to your 
